This paper examines the current state of evidence for long COVID treatments, focusing on the efforts and challenges involved in building a robust clinical trial evidence base for this condition.
The source text provided contains only the title, DOI, journal, and publication date — no abstract, methods, results, or conclusions are available to extract specific findings or limitations.
